Compumedics Limited (CMP) Stock Statistics & Valuation Metrics

Compumedics Limited has a market cap or net worth of AU$62.92M. The enterprise value is AU$74.95M.

Compumedics Limited has 199,761,750 shares outstanding. The number of shares has decreased by -2.65% in one year.

Compumedics Limited’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 1.98%.

The current PE Ratio of Compumedics Limited is 630.0. Compumedics Limited’s PEG ratio is -0.14.

In the last 12 months, Compumedics Limited had revenue of 51.04M and earned -1.27M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was 4.61M and capital expenditures -43.00K, giving a free cash flow of 4.56M billion.

Compumedics Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Compumedics Limited upcoming earnings date is Sep 1, 2026, TBA (Confirmed).

Compumedics Limited as a current ratio of 1.10, with Debt / Equity ratio of 60.04%

In the past 12 months, Compumedics Limited has paid 679.00K in taxes.

Compumedics Limited EV to EBITDA ratio is 29.67, with an EV/FCF ratio of 123.18.

Compumedics Limited has AU$2.00M in cash and marketable securities with AU$14.03M in debt, giving a net cash position of -AU$12.03M billion.

Gross margin is 58.30%, with operating margin of 1.40%, and net profit margin of -2.49%.

The average price target for Compumedics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―